UHAC 62 XX tablet

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Healthy

Phase 1

Bioequivalence Study of UHAC 62 XX Tablets Compared With Capsules in Healthy Volunteers

CompletedNCT02180490

Boehringer IngelheimHealthy

Start: 2002-05-31Updated: 2014-07-08

Bioequivalence Study of UHAC62XX Tablets Compared With Capsules in Healthy Volunteers

CompletedNCT02187575

Boehringer IngelheimHealthy

Start: 2002-07-31Updated: 2014-07-14